Please use this identifier to cite or link to this item: https://hdl.handle.net/11000/39354
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGarcía-Cervera, Carles-
dc.contributor.authorJover-Diaz, Francisco Mariano-
dc.contributor.authorDelgado Sánchez, Elisabet-
dc.contributor.authorMartin-González, Coral-
dc.contributor.authorProvencio-Arranz, Rosa-
dc.contributor.authorInfante-Urrios, Ana-
dc.contributor.authorDólera Moreno, Cristina-
dc.contributor.authorEsteve-Atiénzar, Pedro-
dc.contributor.authorMartínez Lazcano, Teresa-
dc.contributor.authorPeris García, Juan Jorge-
dc.contributor.authorGiner Galvañ, Vicente-
dc.contributor.authorOrtiz de la Tabla Ducasse, Victoria-
dc.contributor.authorSánchez-Miralles, Ángel-
dc.contributor.authorAznar-Saliente, Teresa-
dc.contributor.otherDepartamentos de la UMH::Medicina Clínicaes_ES
dc.date.accessioned2026-02-19T16:08:53Z-
dc.date.available2026-02-19T16:08:53Z-
dc.date.created2024-09-
dc.identifier.citationInfect Chemother . 2024 Sep;56(3):351-360es_ES
dc.identifier.issn2093-2340-
dc.identifier.urihttps://hdl.handle.net/11000/39354-
dc.description.abstractAntibiotic Stewardship Programs (ASP) have improved empirical and directed antibiotic treatment in Gram-negative Bacilli (GNB) bloodstream infections. A decrease in mortality, readmission, and length of hospitalization has been reported. Materials and methods: A pre-post-quasi-experimental study was conducted between November and April 2015-2016 (pre-intervention period), 2016-2017, 2017-2018, and 2018-2019 (post-intervention periods), to analyse the impact of ASP on empirical, directed, and entire treatment optimization, as well as mortality, readmission, and length of hospitalization, in hospitalized patients with Gram-negative bacilli (GNB) bloodstream infections. Results: One hundred seventy-four patients were included (41 in the pre-intervention group, 38 in the first-year post-intervention group, 50 in the second-year post-intervention group, and 45 in the third-year post-intervention group). There was a significant improvement in directed treatment optimization (43.9% in the pre-intervention group, 68.4% in the first-year post-intervention group, 74% in the second-year post-intervention group, and 88.9% in the third-year post-intervention group, P <0.001), as well as in entire treatment optimization (19.5%, 34.2%, 40.0%, and 46.7%, respectively, P=0.013), with increased optimal directed (adjusted odds ratio [aOR], 3.71; 95% confidence interval [CI], 1.60-8.58) and entire treatment (aOR, 3.31; 95% CI, 1.27-8.58). Although a tendency toward improvement was observed in empirical treatment after ASP implementation, it did not reach statistical significance (41.5% vs. 57.9%, P=0.065). No changes in mortality, readmission, or length of hospitalization were detected. Conclusion: ASP implementation improved both directed and entire treatment optimization in patients with GNB bloodstream infections over time. Nevertheless, no improvement was found in clinical outcomes such as mortality, readmission, or length of hospitalization.es_ES
dc.formatapplication/pdfes_ES
dc.format.extent10es_ES
dc.language.isoenges_ES
dc.publisherla Sociedad Coreana de Enfermedades Infecciosas (KSID)es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectantibiotic stewardship programses_ES
dc.subjectbloodstream infectionses_ES
dc.subjectgram-negative bacillies_ES
dc.titleImpact of Implementing an Antimicrobial Stewardship Program for Optimizing Antibiotic Treatment in Gram-negative Bacilli Bacteremiaes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversion10.3947/ic.2024.0026es_ES
Appears in Collections:
Artículos Medicina Clínica


Thumbnail

View/Open:
 Impact of Implementing an Antimicrobial Stewardship Program for Optimizing Antibiotic Treatment in Gram-negative Bacilli Bacteremia.pdf

1,79 MB
Adobe PDF
Share:


Creative Commons ???jsp.display-item.text9???